P

Inventor

PAPATHANASSIU ADONIA E

US10 patents
⚠️ This page may combine multiple inventors who share the name “PAPATHANASSIU ADONIA E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ENTREMED INC

3 patents
US5981471ANov 9, 1999

Compositions and methods for inhibiting cellular proliferation

ENTREMED INC50 citations95
US6593291B1Jul 15, 2003

Compositions and methods of use of ligands that bind components of the blood coagulation/clotting pathway for the treatment of cancer and angiogenic-based disease

ENTREMED INC38 citations92
US6734163B2May 11, 2004

Compositions and methods for inhibiting cellular proliferation

ENTREMED INC9 citations73

ERGON PHARMACEUTICALS LLC

3 patents
US6528489B1Mar 4, 2003

Mycotoxin derivatives as antimitotic agents

ERGON PHARMACEUTICALS LLC14 citations81
US10941109B2Mar 9, 2021

Compositions and methods of treatment using a BCAT1 inhibitor

ERGON PHARMACEUTICALS LLC0 citations60
US7381799B2Jun 3, 2008

Compositions and methods for inhibiting angiogenesis

ERGON PHARMACEUTICALS LLC5 citations60

CHILDRENS MEDICAL CENTER

2 patents
US6673828B1Jan 6, 2004

Analogs of 2-Phthalimidinoglutaric acid

CHILDRENS MEDICAL CENTER110 citations96
US7112602B2Sep 26, 2006

Methods of treating undesired angiogenesis with 2-methyl-EM-138

CHILDRENS MEDICAL CENTER30 citations90

ENTRE MED INC

1 patent
US6946439B2Sep 20, 2005

Compositions and methods for inhibiting cellular proliferation comprising TFPI fragments

ENTRE MED INC9 citations68

PAPATHANASSIU ADONIA E

1 patent
US9422224B2Aug 23, 2016

Methods of treatment using a BCAT1 inhibitor

PAPATHANASSIU ADONIA E0 citations44